In one paragraphArticle in Journal of bacteriology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Benjamin P DarwitzDepartment of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, , Chapel Hill, North Carolina, USA.ORCID 0000-0002-0936-384X Zachary J LifschinDepartment of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, , Chapel Hill, North Carolina, USA.
Claire M MillerDepartment of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, , Chapel Hill, North Carolina, USA.
Christopher J GenitoDepartment of Biomedical Sciences, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-9044-964X Casei A GossettDepartment of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Kyla E AugustineDepartment of Biomedical Sciences, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Lance R ThurlowDepartment of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, , Chapel Hill, North Carolina, USA.ORCID 0000-0003-1839-2922 Funding
Diabetes and Antibiotic Treatment FailureR01AI173004 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian Patrick Conlon, Lance R. Thurlow · 2023 to 2026
$2.8MImpact of hyperglycemia on the pathogenesis of chronic bacterial lung infectionR21AI174088 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THURLOW, LANCE R., WOLFGANG, MATTHEW C · 2023 to 2024
$411kNational Institute of Allergy and Infectious Diseases R01AI173004, R21AI14088NIAID NIH HHS R01 AI173004NIAID NIH HHS R21 AI174088
6 · The paper itselfAbstract
Individuals with poorly controlled diabetes mellitus often develop multispecies skin and soft tissue infections, with
Indexed as
Anti-Bacterial AgentsDrug Resistance, BacterialHyperglycemiaPseudomonas aeruginosaPseudomonas InfectionsStaphylococcal InfectionsStaphylococcus aureusAnimalsCoinfectionGlucoseMiceMice, Inbred C57BLMicrobial Sensitivity TestsQuorum SensingRifampinAnti-Bacterial AgentsGlucoseRifampinantimicrobial resistanceinfectious diseaseMRSA
Identifiers
PMID41099515
PMCPMC12632273
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390